First renal failure and diabetes guidelines published
The first UK national guidelines for people with diabetes who are being treated with haemodialysis for end stage renal failure (ESRF) during inpatient care have been published.
The Management of Adults with Diabetes on the Haemodialysis Unit document has been published by the Joint British Diabetes Societies (JBDS) for Inpatient Care in conjunction with the Renal Association.
Issues, such as organisation of care, assessment of glycaemic control and antidiabetic therapies have been addressed in the guidelines.
It highlights the “organisational difficulties that patients with diabetes on regular hospital haemodialysis experience and the great need for the organisation of their care to be better managed”.
Chronic kidney disease (CKD) and type 2 diabetes are long term conditions that are recognised as major public health concerns in the UK.
Diabetes is currently the leading cause of end-stage renal failure (ESRF) in the
developed world accounting for 25 per cent of incident cases in the UK.
With the number of adults with type 2 diabetes increasing, it is expected that ESRF is therefore expected to become even more prevalent in the future.
Diabetes is a well-recognised risk factor for cardiovascular disease, which is the leading cause of morbidity and mortality in these patients.
Unfortunately mortality rates for dialysis patients are still high and people with diabetes are at a particularly high risk.
A number of areas relating to diabetes care of people on maintenance haemodialysis (MHDx) remain poorly understood, including targets for glycaemic control and treatment algorithms to achieve them.
The guidelines, which were compiled by leading experts in diabetes and nephrology; including senior clinicians, specialty nurses, dietitians and podiatrists, also identified gaps in knowledge and research recommendations on various subjects, such as nutritional support.
The guidelines are just part of the work the Association of British Clinical Diabetologists (ABCD) and the Renal Association are doing in the area of promoting better care for kidey disease.